Renal Denervation: Is It Ready for Prime Time?

被引：12

作者：

Lauder, Lucas ^{[1
]}

Wolf, Milan A. ^{[1
]}

Scholz, Sean S. ^{[1
]}

Hohl, Mathias ^{[1
]}

Mahfoud, Felix ^{[1
,2
]}

Boehm, Michael ^{[1
]}

机构：

[1] Saarland Univ, Med Ctr, Univ Klinikum Saarlandes, Klin Innere Med 3,Kardiol,Angiol,Internist Intens, D-66421 Homburg, Germany

[2] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA

来源：

CURRENT CARDIOLOGY REPORTS | 2019年 / 21卷 / 08期

关键词：

Renal denervation; Device-based therapy; Hypertension; Interventional cardiology; TREATMENT-RESISTANT HYPERTENSION; BLOOD-PRESSURE; SYMPATHETIC DENERVATION; ATRIAL-FIBRILLATION; ARTERY DENERVATION; SYMPLICITY HTN-3; NERVOUS-SYSTEM; ADHERENCE; TRIAL; PATHOPHYSIOLOGY;

D O I：

10.1007/s11886-019-1164-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of ReviewInterventional cardiology and in particular the field of renal denervation is subject to constant change. This review provides an up to date overview of renal denervation trials and an outlook on what to expect in the future.Recent FindingsAfter the sham-controlled SYMPLICITY HTN-3 trial dampened the euphoria following early renal denervation trials, the recently published results of the sham-controlled SPYRAL HTN and RADIANCE HTN trials provided proof-of-principle for the blood pressure-lowering efficacy of renal denervation. However, these studies underline the major issue of patients' non-adherence to antihypertensive medication as well as the need for reliable patient- and procedure-related predictors of response.SummaryThe second generation of sham-controlled renal denervation trials provided proof of principle for the blood pressure-lowering efficacy of RDN. However, larger trials have to assess long-term safety and efficacy.

引用

页数：8

共 50 条

[1] Renal denervation: ready for prime time?
Naehle, C. P.
Schild, H.
Wilhelm, K.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (43) : 2212 - 2218
[2] Renal Denervation: Is It Ready for Prime Time?
Lucas Lauder
Milan A. Wolf
Sean S. Scholz
Mathias Hohl
Felix Mahfoud
Michael Böhm
Current Cardiology Reports, 2019, 21
[3] Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
Laffin, Luke J.
Bakris, George L.
AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (09) : 841 - 846
[4] Renal Denervation: the Time is Not Yet Ready for Commercial Use
Menne, Jan
AKTUELLE KARDIOLOGIE, 2019, 8 (05) : 385 - 388
[5] Not ready for prime time
Cyprych, G
COMPUTER, 2002, 35 (08) : 7 - 7
[6] Not ready for prime time
Isaacs, J
BULLETIN OF THE ATOMIC SCIENTISTS, 2000, 56 (05) : 20 - 21
[7] Ready for prime time
Edwards, M
COMMUNICATIONS NEWS, 1997, 34 (10): : 80 - 81
[8] Ready for Prime Time?
Eckert, Steven E.
INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2011, 26 (05) : 925 - 925
[9] Not ready for prime time
Gumus, Pinar
Chalew, Stuart
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (1-2): : 5 - 6
[10] Ready for Prime Time
Selkoe, Dennis J.
Morris, John C.
SCIENTIST, 2012, 26 (02): : 26 - 27

← 1 2 3 4 5 →